C. Devine

发表

Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.

S. Rangwala, J. Monahan, N. Siegel, 1997, Journal of immunology.

Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica

C. Lanusse, L. Álvarez, I. Fairweather, 2011, Parasitology Research.

Erratum to: Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica

C. Lanusse, L. Álvarez, I. Fairweather, 2011, Parasitology Research.

Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole

C. Lanusse, L. Álvarez, I. Fairweather, 2010, Parasitology Research.

Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.

C. Lanusse, L. Álvarez, I. Fairweather, 2012, Veterinary parasitology.

Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.

C. Lanusse, L. Álvarez, I. Fairweather, 2011, Veterinary parasitology.

Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica

C. Lanusse, L. Álvarez, I. Fairweather, 2010, Parasitology.

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica

C. Lanusse, L. Álvarez, I. Fairweather, 2010, Parasitology Research.

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

C. Lanusse, L. Álvarez, I. Fairweather, 2009, Parasitology.

Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.

I. Fairweather, C. Devine, G. Brennan, 2010, Veterinary parasitology.

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

C. Lanusse, L. Álvarez, I. Fairweather, 2008, Parasitology.

Inhibition of heat shock protein 90 (Hsp90) with the novel agent IPI-504 in metastatic GIST following failure of tyrosine kinase inhibitors (TKIs) or other sarcomas: Clinical results from phase I trial

G. Demetri, S. George, C. Devine, 2008 .

Restricted association between biotypes and serotypes within group A streptococci

C. Devine, F. Grimont, P. Geslin, 1994, Journal of clinical microbiology.